相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A novel class of selective non-nucleoside inhibitors of human DNA methyltransferase 3A
Sunzeyu Huang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2021)
Features and mechanisms of canonical and noncanonical genomic imprinting
Courtney W. Hanna et al.
GENES & DEVELOPMENT (2021)
Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells
Qiufen Zhang et al.
Acta Pharmaceutica Sinica B (2021)
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia
Melissa B. Pappalardi et al.
NATURE CANCER (2021)
Structure-Guided Identification of DNMT3B Inhibitors
Ana S. Newton et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Targeting epigenetic protein-protein interactions with small-molecule inhibitors
Brian M. Linhares et al.
FUTURE MEDICINAL CHEMISTRY (2020)
Molecular mechanisms of KDM5A in cellular functions: Facets during development and disease
R. Kirtana et al.
EXPERIMENTAL CELL RESEARCH (2020)
Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials
Haiying Lu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners
Jonathan E. Sandoval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Gypsum-DL: an open-source program for preparing small-molecule libraries for structure-based virtual screening
Patrick J. Ropp et al.
JOURNAL OF CHEMINFORMATICS (2019)
DNA methyltransferases: emerging targets for the discovery of inhibitors as potent anticancer drugs
Jie Yu et al.
DRUG DISCOVERY TODAY (2019)
Key Topics in Molecular Docking for Drug Design
Pedro H. M. Torres et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Targeting epigenetic machinery: Emerging novel allosteric inhibitors
Fei Ye et al.
PHARMACOLOGY & THERAPEUTICS (2019)
The R882H substitution in the human de novo DNA methyltransferase DNMT3A disrupts allosteric regulation by the tumor supressor p53
Jonathan E. Sandoval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Insight into the selective binding mechanism of DNMT1 and DNMT3A inhibitors: a molecular simulation study
Tianli Xie et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2019)
Targeting a Subpocket in Trypanosoma brucei Phosphodiesterase B1 (TbrPDEB1) Enables the Structure-Based Discovery of Selective Inhibitors with Trypanocidal Activity
Antoni R. Blaazer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
SWISS-MODEL: homology modelling of protein structures and complexes
Andrew Waterhouse et al.
NUCLEIC ACIDS RESEARCH (2018)
Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells
Luc Gailhouste et al.
CELL DEATH & DISEASE (2018)
Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo
Mira Jeong et al.
CELL REPORTS (2018)
Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy
Subhankar Biswas et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Epigenetic regulation of MAGE family in human cancer progression-DNA methylation, histone modification, and non-coding RNAs
Yishui Lian et al.
CLINICAL EPIGENETICS (2018)
CHARMM36m: an improved force field for folded and intrinsically disordered proteins
Jing Huang et al.
NATURE METHODS (2017)
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
Wei Qi et al.
NATURE CHEMICAL BIOLOGY (2017)
Allosteric regulation of epigenetic modifying enzymes
Beth E. Zucconi et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2017)
Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells
O. A. Guryanova et al.
LEUKEMIA (2016)
Identification of potent, selective KDM5 inhibitors
Victor S. Gehling et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia
Rachel E. Rau et al.
BLOOD (2016)
3CAPS-a structural AP-site analogue as a tool to investigate DNA base excision repair
David Schuermann et al.
NUCLEIC ACIDS RESEARCH (2016)
DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation
Junji Koya et al.
NATURE COMMUNICATIONS (2016)
Targeting Polycomb systems to regulate gene expression: modifications to a complex story
Neil P. Blackledge et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
DNA methylation pathways and their crosstalk with histone methylation
Jiamu Du et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Structural insight into autoinhibition and histone H3-induced activation of DNMT3A
Xue Guo et al.
NATURE (2015)
DNMT3A in haematological malignancies
Liubin Yang et al.
NATURE REVIEWS CANCER (2015)
Epigenetic control of myeloid cell differentiation, identity and function
Damiana Alvarez-Errico et al.
NATURE REVIEWS IMMUNOLOGY (2015)
The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers
David A. Russler-Germain et al.
CANCER CELL (2014)
Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemia
Haiyang Yun et al.
HAEMATOLOGICA (2014)
Clinical development of demethylating agents in hematology
Shyamala C. Navada et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells
Sergio Valente et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Induced differentiation of acute myeloid leukemia cells by activation of retinoid X and liver X receptors
P. V. Sanchez et al.
LEUKEMIA (2014)
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit
Sander Pronk et al.
BIOINFORMATICS (2013)
Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG)
Verena I. Gaidzik et al.
BLOOD (2013)
Exploiting an Allosteric Binding Site of PRMT3 Yields Potent and Selective Inhibitors
Feng Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Rapid Synthesis of New DNMT Inhibitors Derivatives of Procainamide
Ludovic Halby et al.
CHEMBIOCHEM (2012)
Mutations in DNA Methyltransferase (DNMT3A) Observed in Acute Myeloid Leukemia Patients Disrupt Processive Methylation
Celeste Holz-Schietinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Automation of the CHARMM General Force Field (CGenFF) II: Assignment of Bonded Parameters and Partial Atomic Charges
K. Vanommeslaeghe et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
An Allosteric Inhibitor of Protein Arginine Methyltransferase 3
Alena Siarheyeva et al.
STRUCTURE (2012)
Histone tails regulate DNA methylation by allosterically activating de novo methyltransferase
Bin-Zhong Li et al.
CELL RESEARCH (2011)
Oligomerization of DNMT3A Controls the Mechanism of de Novo DNA Methylation
Celeste Holz-Schietinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Identification of a second DNA binding site in human DNA methyltransferase 3A by substrate inhibition and domain deletion
Matthew M. Purdy et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
The Inherent Processivity of the Human de Novo Methyltransferase 3A (DNMT3A) Is Enhanced by DNMT3L
Celeste Holz-Schietinger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
Lanlan Shen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
CHARMM General Force Field: A Force Field for Drug-Like Molecules Compatible with the CHARMM All-Atom Additive Biological Force Fields
K. Vanommeslaeghe et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Delivery of 5-Azacytidine to Human Cancer Cells by Elaidic Acid Esterification Increases Therapeutic Drug Efficacy
Bodo Brueckner et al.
MOLECULAR CANCER THERAPEUTICS (2010)
5-azacytidine enhances the anti-leukemic activity of lintuzumab (SGN-33) in preclinical models of acute myeloid leukemia
May Kung Sutherland et al.
MABS (2010)
DNMT3A Mutations in Acute Myeloid Leukemia.
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Polycomb CBX7 Promotes Initiation of Heritable Repression of Genes Frequently Silenced with Cancer-Specific DNA Hypermethylation
Helai P. Mohammad et al.
CANCER RESEARCH (2009)
A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation
Jharna Datta et al.
CANCER RESEARCH (2009)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing
Quan Zhao et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
Carlo Stresemann et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation
Berk Hess et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2008)
Epigenetic interplay between histone modifications and DNA methylation in gene silencing
Thomas Vaissiere et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis
Joanne L. Attema et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Epigenetics in development
Julie C. Kiefer
DEVELOPMENTAL DYNAMICS (2007)
Association of Dnmt3a and thymine DNA glycosylase links DNA methylation with base-excision repair
Ya-Qiang Li et al.
NUCLEIC ACIDS RESEARCH (2007)
Reconstitution and mechanism of the stimulation of de novo methylation by human DNMT3L
Michael S. Kareta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Discovery of two novel, small-molecule inhibitors of DNA methylation
P Siedlecki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
GATC flanking sequences regulate dam activity:: Evidence for how Dam specificity may influence pap expression
SN Peterson et al.
JOURNAL OF MOLECULAR BIOLOGY (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
DNA methyltransferase-3a interacts with p53 and represses p53-mediated gene expression
YA Wang et al.
CANCER BIOLOGY & THERAPY (2005)
Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases
B Brueckner et al.
CANCER RESEARCH (2005)
Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein
A Kuzmichev et al.
GENES & DEVELOPMENT (2002)
Role of histone H3 lysine 27 methylation in polycomb-group silencing
R Cao et al.
SCIENCE (2002)
Latent and active p53 are identical in conformation
A Ayed et al.
NATURE STRUCTURAL BIOLOGY (2001)
Sensitization by 5-aza-2′-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1α,25-dihydroxyvitamin D3
N Niitsu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
分享论文
